ACC GUIDELINES Bundle (free trial)

Supraventricular Tachycardia

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/600057

Contents of this Issue

Navigation

Page 6 of 33

5 Table 2. Acute Treatment of SVT of Unknown Mechanism COR LOE Recommendations I B-R Vagal maneuvers are recommended for acute treatment in patients with regular SVT. I B-R Adenosine is recommended for acute treatment in patients with regular SVT. I B-NR Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible. I B-NR Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated. IIa B-R IV diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable SVT. IIa C-LD IV beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT. Colors in tables and figures correspond to Class of Recommendation Table on pages 30-31. Treatment Figure 2. Acute Treatment of SVT of Unknown Mechanism Regular SVT Hemodynamically stable YES NO IV beta blockers, IV diltiazem, or IV verapamil (Class IIa) Synchronized cardioversion a (Class I) If ineffective or not feasible Synchronized cardioversion a (Class I) a For rhythms that break or recur spontaneously, synchronized cardioversion is not appropriate. Vagal maneuvers and/or IV adenosine (Class I) If ineffective or not feasible

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle (free trial) - Supraventricular Tachycardia